Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase 1, Phase 2, Recruiting

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

for
Clinical Stage IV Gastric Cancer AJCC v8,
Location: Greenlawn NY, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04329494

Phase 1, Recruiting

A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult, Lymphoma
Location: Houston TX, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04983810

Phase 1, Phase 2, Recruiting

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

for
Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT06242912

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

for
Febrile Neutropenia, Non-myeloid Malignancy
Location: Myrtle Beach SC, Charlotte NC, Rock Hill SC
Sponsor: Coherus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04662892

Recruiting

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

for
Solid Tumor, Adult
Location: Commack NY, Harrison NY, New York NY, Middletown NJ,
Sponsor: Effector Therapeutics

Sex: All

Age: 18+

Code: NCT04092673

Phase 1, Phase 2, Recruiting

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

for
Hot Flashes, Breast Cancer
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: Female

Age: 18+

Code: NCT01530373

Phase 2, Recruiting

TR(ACE) Assay Clinical Specimen Study

for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: East Setauket NY, Toms River NJ, Flemington NJ,
Sponsor: Biological Dynamics

Sex: All

Age: 21+

Code: NCT02934360

Recruiting

Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors

for
Solid Tumor
Location: Houston TX, Gilbert AZ
Sponsor: Virogin Biotech Canada Ltd

Sex: All

Age: 18+

Code: NCT05266612

Phase 1, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for
Solid Tumors With HRAS Alterations,
Location: Boston MA, New Brunswick NJ, Pittsburgh PA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase 1, Recruiting

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Cincinnati OH
Sponsor: Jubilant Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05268666

Phase 1, Phase 2, Recruiting

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Fairfax VA, Irving TX, Austin TX, San Antonio TX
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT06090266

Phase 1, Phase 2, Recruiting

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

for
Pediatric Cancer, Adolescent and Young Adult Cancer
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 15 - 25

Code: NCT06982066

Recruiting

Investigation of Stem Cells in Human Lipoaspirate

for
Breast Cancer
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas

Sex: All

Age: 18 - 70

Code: NCT01677520

Recruiting

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

for
Metastatic Malignant Neoplasm in the Brain,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05222620

Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial